HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Webby Awards call for entries

This article was originally published in The Rose Sheet

Executive Summary

Submissions are being accepted through Dec. 14 at 1www.WebbyAwards.com for the 12 Annual Webby Awards' Best Beauty and Cosmetics Site of the year, according to Sept. 19 release. Last year, the Webby Awards - "hailed as the 'Oscars of the Internet' by the New York Times" - received a record 8,000 entries from over 60 countries; campaign for Philips Norelco Bodygroom claimed the top prize in the beauty and cosmetics category (2"The Rose Sheet" April 16, 2007, p. 5). This year's nominees will be announced in April 2008, and winners will be honored at the gala ceremony in June. Webby Awards is presented by the International Academy of Digital Arts and Sciences, a 550-panel judging academy whose members include Vinton Cerf, co-founder of the Internet Society; Bob Greenberg, CEO of advertising agency R/GA; "Simpsons" creator Matt Groening; author Arianna Huffington; and film producer Harvey Weinstein...

You may also be interested in...



Male Grooming Promos Capture Webby Award Nominations

Nominees for the 11 Annual Webby Awards' Best Beauty and Cosmetics Site of the Year highlight the creativity of online promotions targeting young men

Chinese Firms Up Their Game In Novel Flu Antiviral Development

Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.

Quotable: Words Of Wisdom From Our Recent APAC Coverage

Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014999

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel